Although TP53 is a biologically important gene and is often affected in CHIP, its clinical relevance beyond myeloid neoplasms (1, 5) and cancer treatment (1, 2, 6) is unclear due to an inadequate evaluation. The gene discussed is STUB1; the disease is myeloid neoplasm.